Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease

J Crohns Colitis. 2016 May;10(5):541-8. doi: 10.1093/ecco-jcc/jjw003. Epub 2016 Jan 12.

Abstract

Background and aims: Acute optic neuritis [ON] is an inflammatory condition affecting the optic nerve. Clinicians should suspect optic neuritis in cases of painful and rapidly progressive loss of central visual field. This condition may be associated with a multitude of diseases, and mostly with multiple sclerosis [MS] where it may present as an initial symptom. The literature reports that optic neuritis and MS occur in patients with inflammatory bowel disease [IBD] before and after the era of anti-tumour necrosis factor-α [TNFα] drugs. At the present moment, there is little consensus for managing this complication, currently treated with corticosteroids and discontinuation of the causative agents.

Methods: We collected cases through a retrospective multicentre European Crohn's and Colitis Organisation CONFER [COllaborative Network For Exceptionally Rare case reports] project. We also performed a comprehensive retrospective search of the available literature on this topic.

Results: We report herein 12 new cases of ON, including 10 under anti-TNF therapy, collected through the CONFER project. We also compare characteristics of ON associated or not with anti-TNFα agents.

Conclusions: The exceptional and current observation of distant family history of MS in 17% of our patients who developed ON, despite the small number and the lack of a control arm, might be an important signal that should be taken into account in our therapeutic strategies in the future.

Keywords: Inflammatory bowel disease; anti-TNF; multiple sclerosis; optic neuritis; papillitis; retrobulbar neuritis.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adalimumab / therapeutic use*
  • Adult
  • Anti-Inflammatory Agents / therapeutic use*
  • Certolizumab Pegol / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammatory Bowel Diseases / complications*
  • Inflammatory Bowel Diseases / drug therapy
  • Infliximab / therapeutic use*
  • Male
  • Middle Aged
  • Multiple Sclerosis / complications
  • Optic Neuritis / etiology*
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-Inflammatory Agents
  • Infliximab
  • Adalimumab
  • Certolizumab Pegol